Yasho Industries Ltd
Yasho Industries Ltd is a manufacturer of specialty chemicals, food antioxidants, aroma chemicals, rubber accelerators and lubricant additives. It has a wide geographical presence with exports to Europe, America, Middle East and Asia.[1]
- Market Cap ₹ 1,940 Cr.
- Current Price ₹ 1,702
- High / Low ₹ 2,427 / 1,514
- Stock P/E 58.2
- Book Value ₹ 259
- Dividend Yield 0.03 %
- ROCE 12.7 %
- ROE 21.5 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 36.9% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 29.2%
Cons
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chemicals
Part of BSE Allcap BSE Commodities BSE SmallCap
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|
169 | 180 | 195 | 250 | 340 | 297 | 359 | 614 | 670 | 596 | 639 | |
154 | 160 | 174 | 223 | 303 | 257 | 310 | 520 | 560 | 497 | 536 | |
Operating Profit | 15 | 20 | 22 | 27 | 37 | 40 | 49 | 93 | 111 | 99 | 103 |
OPM % | 9% | 11% | 11% | 11% | 11% | 13% | 14% | 15% | 17% | 17% | 16% |
2 | 0 | 3 | 4 | 3 | 3 | 10 | 10 | 11 | 8 | 9 | |
Interest | 13 | 13 | 14 | 15 | 16 | 16 | 16 | 14 | 16 | 15 | 36 |
Depreciation | 5 | 5 | 5 | 6 | 7 | 10 | 12 | 19 | 20 | 16 | 32 |
Profit before tax | 0 | 2 | 5 | 10 | 17 | 17 | 31 | 71 | 86 | 76 | 44 |
Tax % | 50% | 33% | 33% | 22% | 29% | 29% | 30% | 26% | 26% | 25% | |
0 | 2 | 4 | 8 | 12 | 12 | 21 | 53 | 64 | 57 | 33 | |
EPS in Rs | 0.01 | 0.15 | 0.37 | 7.31 | 10.91 | 11.05 | 19.71 | 46.26 | 56.41 | 50.11 | 29.23 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 3% | 1% | 1% | 1% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 12% |
3 Years: | 18% |
TTM: | 9% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 37% |
3 Years: | 39% |
TTM: | -32% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 72% |
3 Years: | 14% |
1 Year: | 4% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 29% |
3 Years: | 29% |
Last Year: | 22% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 7 | 10 | 10 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
Reserves | 2 | 4 | 7 | 23 | 35 | 47 | 68 | 162 | 226 | 282 | 284 |
121 | 126 | 132 | 153 | 151 | 169 | 162 | 179 | 324 | 579 | 634 | |
28 | 29 | 29 | 45 | 54 | 51 | 65 | 131 | 87 | 119 | 139 | |
Total Liabilities | 157 | 168 | 178 | 232 | 250 | 278 | 305 | 483 | 648 | 992 | 1,069 |
57 | 55 | 58 | 69 | 73 | 106 | 120 | 161 | 177 | 203 | 636 | |
CWIP | 0 | 0 | 0 | 0 | 23 | 12 | 0 | 1 | 124 | 461 | 0 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 5 |
100 | 113 | 120 | 162 | 154 | 160 | 185 | 322 | 347 | 323 | 428 | |
Total Assets | 157 | 168 | 178 | 232 | 250 | 278 | 305 | 483 | 648 | 992 | 1,069 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
20 | -5 | 54 | 31 | 35 | 16 | 14 | 90 | |||
-8 | -17 | -33 | -30 | -14 | -59 | -132 | -304 | |||
-10 | 15 | -20 | -1 | -21 | 42 | 118 | 214 | |||
Net Cash Flow | 2 | -7 | 0 | -0 | 0 | -1 | 0 | 0 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 60 | 67 | 80 | 80 | 63 | 74 | 73 | 78 | 59 | 76 |
Inventory Days | 196 | 222 | 171 | 160 | 108 | 142 | 125 | 125 | 140 | 118 |
Days Payable | 73 | 71 | 56 | 72 | 64 | 64 | 72 | 105 | 45 | 45 |
Cash Conversion Cycle | 184 | 219 | 195 | 167 | 106 | 152 | 126 | 99 | 154 | 150 |
Working Capital Days | 148 | 166 | 148 | 142 | 92 | 115 | 103 | 101 | 130 | 140 |
ROCE % | 11% | 14% | 15% | 17% | 15% | 20% | 29% | 22% | 13% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
2d - With respect to Investor / Analysts meet scheduled to be held on November 27, 2024
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
2d - Earnings conference call transcript for Q2FY25.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
14 Nov - Audio recording of Q2FY25 conference call available.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
14 Nov - Extract of Q2FY25 results published in newspaper
- Announcement under Regulation 30 (LODR)-Investor Presentation 13 Nov
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
Concalls
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT REC
-
May 2024TranscriptPPT
-
May 2024Transcript PPT REC
-
Feb 2024TranscriptPPTREC
-
Feb 2024TranscriptNotesPPT REC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Nov 2022TranscriptNotesPPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
May 2021TranscriptNotesPPT
-
Feb 2021TranscriptNotesPPT
-
Nov 2020TranscriptNotesPPT
-
Oct 2020TranscriptNotesPPT
Company Overview
The company operates in specialty and fine chemicals manufacturing and manufactures 148 products across five business verticals - Food Antioxidants, Aroma Chemicals, Rubber Chemicals, Lubricant Additives, and Specialty Chemicals. It has a customer base across the world including the USA, Europe, Asia, and the Middle East. [1]